Navigation Links
Valeant Pharmaceuticals to Present at RBC Capital Markets' 2011 Healthcare Conference
Date:2/16/2011

MISSISSAUGA, Ontario, Feb. 16, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the RBC Capital Markets' 2011 Healthcare Conference on Thursday, March 3, 2011, at 11:00 a.m. ET. The conference will be held at the New York Palace Hotel in New York City, NY.

A live webcast and audio archive of the presentation will be available on the company's website at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.Contact Information:Laurie W. Little949-461-6002laurie.little@valeant.com(Logo:  http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)


'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
2. Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada
3. Valeant Launches Senior Notes Offering
4. Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
5. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
6. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
7. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
8. Valeant Announces Pricing of Senior Notes
9. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
10. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
11. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Feb. 8, 2016 /PRNewswire/--  Cell Applications, Inc. ... tissue-engineering services are now available in ... three-dimensional (3D) bioprinting approach called the "Kenzan Method." ... , a state-of-the-art robotic system that fabricates 3D ... powerful pay-for-service bio-printing model that makes scaffold-free tissue ...
(Date:2/8/2016)... , Feb. 8, 2016  Avista Pharma Solutions ... Eric Setzer as Chief Financial Officer (CFO). Mr. Setzer ... years of experience in various roles within growing technology ... he served as the Executive Director of Finance at ... Raleigh, NC . Previously, Mr. Setzer ...
(Date:2/8/2016)... -- Velano Vascular, a medical technology company transforming and ... practitioners, announced today that the company has raised an ... proceeds from this financing, an extension of a $5 ... support the development and commercialization of the company,s inpatient ... Philadelphia , and a number of ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... , ... Steve Helwig & Associates Insurance & Financial, serving the families of ... up with Citizens Opposed to Domestic Abuse in support of its efforts to provide ... victimized by the fear of violence in their own homes, donations may now be ...
(Date:2/8/2016)... San Francisco, CA (PRWEB) , ... February 08, 2016 , ... ... helped raise $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently ... who also was the American Cancer Society’s 2015 CEO of the Year , ...
(Date:2/8/2016)... IL (PRWEB) , ... February 08, 2016 , ... ... conditions that co-occur frequently. While a significant number of women and men with ... not the trauma itself, that best predicts the development of an eating disorder. ...
(Date:2/8/2016)... Encinitas, CA (PRWEB) , ... February 08, 2016 ... ... study showing greater than 50% lower incidence rate of type 2 diabetes in ... national averages. ”It is time to make a change in public health,” states ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua Rosenthal, PhD, ... healthcare companies can use newly released government data on populations and physicians to ... intervene and capture the value they create to succeed in new economic models ...
Breaking Medicine News(10 mins):